JP
John F. Paolini (CHIEF MEDICAL OFFICER) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $8.8M of KNSA (94,397 sh across 8 lots, as filed), executed Oct 30. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$13.7M
shares × price, as filed
Last traded
Nov 2
Filed Nov 3
Median ADV $60.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $17.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
KNSARecent filings
KNSASALE
Kiniksa Pharmaceuticals International, plc
View filing →
$8.8M94,397 sh across 8 lots
Exec Oct 30
Filed Nov 3 · 6:28 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $3.1M
58,424 sh across 2 lots
Exec May 1
Filed May 5 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $1.8M
40,000 sh across 3 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $3.1M
82,542 sh × $37.14
Exec Oct 31 2025
Filed Nov 4 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $955K
29,325 sh × $32.55
Exec Aug 6 2025
Filed Aug 8 2025 · 5:30 PM ET